Silpita Paul

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Data from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2025 DOI: 10.1158/2326-6066.c.6551210
  +Save
• Supplementary Figures from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2025 DOI: 10.1158/2326-6066.30720876
  +Save
• Supplementary Tables from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2025 DOI: 10.1158/2326-6066.30720873
  +Save
• The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting
  Cancer Control 2025 DOI: 10.1177/10732748251406677
  +Save
• Data from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2023 DOI: 10.1158/2326-6066.c.6551210.v1
  +Save
• Supplementary Figures from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2023 DOI: 10.1158/2326-6066.22546568
  +Save
• Supplementary Figures from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2023 DOI: 10.1158/2326-6066.22546568.v1
  +Save
• Supplementary Tables from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2023 DOI: 10.1158/2326-6066.22546565
  +Save
• Supplementary Tables from Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  2023 DOI: 10.1158/2326-6066.22546565.v1
  +Save
• Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses
  Cancer Immunology Research 2023 DOI: 10.1158/2326-6066.CIR-21-1073
  +Save